The annual report is a positive read in my view as the numbers clearly show:Financial Summary (key metrics)
Note: the non cash addback was primarily the complete write off of $8.1m for Xanada (TP/15) which now written off can never re-occur.
2022
2021
1 Profit & Loss Statement:
2 Revenue
$19.4m
$6.7m
3 Reported Profit/(Loss) from continued operations
$(7.7)m
$(3.9)m
4 Non cash addbacks:
$11.9m
$4.0m
5 Adjusted Profit/(Loss) for non cash items
$4.2m
$0.1m
6 7 Cash Flow:
8 Net Cash Flow from Operating Activities
$6.0m
$(5.5)m
9 10 Balance Sheet:
11 Cash on Hand
$13.8m
$0.6m
12 Borrowings
$nil
$0.3m
More points to come as I wade through the report.
IMO and DYOR.
The annual report is a positive read in my view as the numbers...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TEG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.320M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 41860 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 84490 | 2 |
View Market Depth
| Last trade - 09.42am 04/09/2024 (20 minute delay) ? |
| TEG (ASX) Chart |
Day chart unavailable